Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H.
Hatakeyama H, et al. Among authors: ishida t, ishida e.
Int J Pharm. 2007 Sep 5;342(1-2):194-200. doi: 10.1016/j.ijpharm.2007.04.037. Epub 2007 May 10.
Int J Pharm. 2007.
PMID: 17583453